Gyrodyne LLC Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $2.5MTTM through 30 Jun 2026
Margins
| Current |
|---|
Balance Sheet Health
Debt / Equity0.42x
Net Debt$6.8M
Cash & Equivalents$3.8M
Multi-Year Trend
RevenueFY2014: $2.8M
Diluted EPSFY2014: $-2.09
Dividend
$1.00Per share, FY20170.00%Yield
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Real Estate Portfolio | View detailsThe company is actively pursuing entitlements to maximize the value of its remaining properties prior to sale and subsequent liquidation, with the process expected to extend into 2028. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.